Myeloid Cells: Biology and Regulation, Role in Cancer Progression and Potential Implications for Therapy

$110.00

Spencer A. Douglas (Editor)

Series: Cell Biology Research Progress
BISAC: SCI017000

In this book, the authors present current research in the study of the biology and regulation, role in cancer progression and potential implications for therapy of myeloid cells. Topics discussed include the differentiation signaling induced by retinoic acid and vitamin D3;
proline rich homeodomain (Prh/Hhex) protein in the control of haematopoiesis and myeloid cell proliferation, and its potential as a therapeutic target in myeloid leukaemias and other cancers; apoptosis, cell cycle and epigenetic processes deregulation in myeloproliferative neoplasms; use of animal models to evaluate myeloid cell dysfunction in cancer; use of animal models to evaluate myeloid cell dysfunction in cancer; and the biology of myeloid cells mediating tumor recurrence after radiotherapy. (Imprint: Nova Biomedical )

Clear

Table of Contents

Table of Contents

Preface

Differentiation Signaling Induced by Retinoic Acid and Vitamin D3
(Xiaotang Hu, Graham Shaw, Department of Biology, College of Arts & Sciences, the School of Podiatric Medicine, Barry University, Miami Shores, FL, USA)

Proline Rich Homeodomain (PRH/HHEX) Protein in the Control of Haematopoiesis and Myeloid Cell Proliferation and its Potential as a Therapeutic Target in Myeloid Leukaemias and other Cancers
(R.M. Kershaw, K. Gaston, P.S. Jayaraman, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK, and others)

Apoptosis, Cell Cycle and Epigenetic Processes Deregulation in Myeloproliferative Neoplasms
(Daniela Dover de Araujo, Natalia de Souza Nunes, Raquel Tognon-Ribeiro, Sandra Mara Burin, Fabiola Attié de Castro, Clinical Analyses, Toxicology and Food Sciences Department, School of Pharmaceutical Science of Ribeirão Preto-University of São Paulo, Ribeirão Preto, Brazil, and University of Educational Foundation of Guaxupé- UNIFEG, Minas Gerais, Brazil, and others)

Use of Animal Models to Evaluate Myeloid Cell Dysfunction in Cancer
(Tracey L. Papenfuss, Julie Baker, The Ohio State University, Ohio, USA)

Biology of Myeloid Cells Mediating Tumor Recurrence after Radiotherapy
(G-One Ahn, J. Martin Brown, Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology (POSTECH), Pohang, Gyeongbuk, Korea, and others)

Index

Additional information

Binding

,